All In MedTech

FDA Clearance Tracker · P160030-S031

Freestyle Libre Flash Glucose Monitoring System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 6, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 6, 2019

Approved

Time to decision

98 days

Received Jan 28, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P160030-S031
Device name
Freestyle Libre Flash Glucose Monitoring System
Applicant location
Alameda, CA
Received
Jan 28, 2019
Decided
May 6, 2019
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P160030

Device type

Device class
Class III

Every decision under product code PZE

FDA's approval statement

As written in FDA's record.

Approval for adding the FreeStyle LibreLink App for Android as a compatible reading device and alternative primary display for the FreeStyle Libre System and FreeStyle Libre 14 Day System.

Source documents

Other decisions for Abbott Diabetes Care, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.